Ashley Hawkins Obtains Life Saving Breast Cancer Success Using Innovative GTFC Treatment and Unipathic Medicine at Envita Medical Center
/EINPresswire.com/ -- SCOTTSDALE, AZ--(Marketwired - October 19, 2015) - Struggling with failed cancer treatments at the nation’s leading cancer centers, Ashley Hawkins finally found the elusive treatment protocol that worked to put her breast cancer into remission and save her life. It’s called GTFC or Genetically Targeted Fractionated Chemotherapy; Envita’s highly targeted, and personalized micro dosed chemotherapy. Because of this type of therapy, Ashley did not have to resort to standard, potentially ineffective chemotherapy or the mutilation that comes along with surgery. Instead, she used a combination of GTFC, phytotherapeutics and immunotherapy, which were all based on her unique genetic findings, per Unipathic Medicine guidelines. These were all key factors in getting Ashley well again.
When Ashley first came to Envita she met with Dr. Oertle, one of the leading physicians at the center. He explained that the key to better treatment lies in, “not attacking cancer with 1 regimen but attacking cancer from all different angles.” Ashley and her husband quickly agreed that Unipathic Medicine and more specifically, GTFC was the way to go for her unique case of breast cancer. This is because GTFC can strike multiple targets and uses several different drugs at the same time. This is all due to metronomic dosing, which features chemotherapy being administered in low doses and at equally spaced intervals.
Dr. Dino Prato, founder of Envita, had this to say: “The ability to outperform other cancer centers all starts by understanding that breast cancer is not a disease of simply the breast tissue, but it is in fact a disease of genetic mutations, biomarkers and molecular profiles. By using our unique approach to breast cancer, developed from over 15 years of personalized clinical experience, many patients have improved their outcomes.” Dr. Prato believes that only by establishing a true medical blueprint for each patient, and keeping in mind that each person’s cancer is different, that the best potential treatment options can be revealed.
For more information about breast cancer, or advanced treatment options, visit http://envita.com/. To watch Ashley’s amazing success story on YouTube go here.
Image Available: http://www.marketwire.com/library/MwGo/2015/10/19/11G068138/Images/press_release_envita_cancer-731706925373.jpg
Embedded Video Available: https://www.youtube.com/watch?v=FLenYYlWxXQ
Contact info for this press release is
Envita Medical Center
Marshall Aristide
marshalla@envita.com
Ashley Hawkins used a combination of GTFC, Genetically Targeted Fractionated Chemotherapy and other cancer treatments at Envita Medical Center to achieve remission.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
